Zhongguang Luo

Dr. Zhongguang Luo

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2009 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
ZLZhongguang Luo
Zhongguang Luo
LZLu Zhong
Lu Zhong
XHXiaoFeng Han
XiaoFeng Han
HWHaiRong Wang
HaiRong Wang
JZJiHua Zhong
JiHua Zhong
ZXZhengHua Xuan
ZhengHua Xuan

1 February 2023 in Acta Biochimica et Biophysica Sinica
Verified
Journal Article
Closed access
JLJing Li
Jing Li
WZWanwei Zheng
Wanwei Zheng
JWJie Wu
Jie Wu
JZJun Zhang
Jun Zhang
BLBin Lv
Bin Lv
ZLZhongguang Luo
Zhongguang Luo
Fatty acid oxidation (FAO) has been proven to be an accomplice in tumor progression. Carnitine palmitoyltransferase 1C (CPT1C), a rate-limiting enzyme in FAO, mainly functions to catalyze fatty acid carnitinylation and guarantee subsequent entry into the mitochondria for FAO in colorectal cancer (CRC). Gene expression data and clinical information extracted from The Cancer Genome Atlas (TCGA) database show significantly higher expression of CPT1C in patients with metastatic CRC ( P=0.005). Moreover, overexpression of CPT1C is correlated with worse relapse-free survival in CRC (HR 2.1, P=0.0006), while no statistical significance is indicated for CPT1A and CPT1B. Further experiments demonstrate that downregulation of CPT1C expression leads to a decrease in the FAO rate, suppression of cell proliferation, cell cycle arrest and repression of cell migration in CRC, whereas opposite results are obtained when CPT1C is overexpressed. Furthermore, an FAO inhibitor almost completely reverses the enhanced cell proliferation and migration induced by CPT1C overexpression. In addition, analysis of TCGA data illustrates a positive association between CPT1C expression and HIF1α level, suggesting that CPT1C is a transcriptional target of HIF1α. In conclusion, CPT1C overexpression indicates poor relapse-free survival of patients with CRC, and CPT1C is transcriptionally activated by HIF1α, thereby promoting the proliferation and migration of CRC cells.

9 April 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CNChunhua Ni
Chunhua Ni
XWXiaohong Wang
Xiaohong Wang
SLShaoping Liu
Shaoping Liu
JZJunling Zhang
Junling Zhang
ZLZhongguang Luo
Zhongguang Luo
BXBei Xu
Bei Xu
Immunotherapy had shown good antitumor activity in a variety of solid tumors, but low benefit in CRC, so there was an urgent need to explore new biomarkers. We evaluated the role of KMT2C using publicly available data from the Cancer Genome Atlas (TCGA) and Memorial Sloan Kettering Cancer Center (MSKCC). In addition, further analysis was performed in an internal cohort. Moreover, the mutant profiles of KMT2C was analyzed in a large CRC cohort. The relationship between clinical pathologic features and KMT2C were analyzed with using the two-sided chi-squared test or the Fisher exact test. Clinicopathologic characteristics associated with overall survival using Cox regression and the Kaplan–Meier method. We found that KMT2C-mutated CRC patients in the immunotherapy cohort had significantly improved OS compared with KMT2C WT patients (P = 0.013). However, this phenomenon did not exist in non-immunotherapy cohort. Our cohort validated the value of KMT2C mutations in predicting better clinical outcomes, including ORR (P < 0.0001) and OS (P = 0.010). Meanwhile, KMT2C mutation was associated with higher tumor mutation burden, MSI score, higher levels of immune-associated T cells, neutrophil, and M1-type macrophages. Our study suggested that KMT2C mutation might be a potential positive predictor for CRC immunotherapy.

YTYujen Tseng
Yujen Tseng
Shaocong MoShaocong Mo
Shaocong Mo
YZYanwei Zeng
Yanwei Zeng
WZWanwei Zheng
Wanwei Zheng
HSHuan Song
Huan Song
ZLZhongguang Luo
Zhongguang Luo
Sarcopenia is associated with increased morbidity and mortality in Crohn’s disease. The present study is aimed at investigating the different diagnostic performance of different machine learning models in identifying sarcopenia in Crohn’s disease. Patients diagnosed with Crohn’s disease at our center provided clinical, anthropometric, and radiological data. The cross-sectional CT slice at L3 was used for segmentation and the calculation of body composition. The prevalence of sarcopenia was calculated, and the clinical parameters were compared. A total of 167 patients were included in the present study, of which 127 (76.0%) were male and 40 (24.0%) were female, with an average age of 36.1 ± 14.3 years old. Based on the previously defined cut-off value of sarcopenia, 118 (70.7%) patients had sarcopenia. Seven machine learning models were trained with the randomly allocated training cohort (80%) then evaluated on the validation cohort (20%). A comprehensive comparison showed that LightGBM was the most ideal diagnostic model, with an AUC of 0.933, AUCPR of 0.970, sensitivity of 72.7%, and specificity of 87.0%. The LightGBM model may facilitate a population management strategy with early identification of sarcopenia in Crohn’s disease, while providing guidance for nutritional support and an alternative surveillance modality for long-term patient follow-up.

5 February 2025 in Human Genomics
Verified
Journal Article
Open access
PDF file
WLWenshuai Li
Wenshuai Li
LCLirong Chen
Lirong Chen
QZQi Zhou
Qi Zhou
THTiansheng Huang
Tiansheng Huang
WZWanwei Zheng
Wanwei Zheng
JLJie Liu
Jie Liu
The progression of liver fibrosis involves complex interactions between hepatic stellate cells (HSCs) and multiple immune cells in the liver, including macrophages. However, the mechanism of exosomes in the crosstalk between liver macrophages and HSCs remains unclear. Exosomes were extracted from primary mouse macrophages and cultured with HSCs, and the differential expression of microRNAs was evaluated using high-throughput sequencing technology. The functions of miR-342-3p in exosomes were verified by qPCR and luciferase reporter gene experiments with HSCs. The function of the target gene Hippocalcin-like protein 1 (HPCAL1) in HSCs was verified by Western blotting, qPCR, cellular immunofluorescence and co-IP in vivo and in vitro. We demonstrated that exosomal microRNA-342-3p derived from primary liver macrophages could activate HSCs by inhibiting the expression of HPCAL1 in HSCs. HPCAL1, which is a fibrogenesis suppressor, could inhibit TGF-β signaling in HSCs by regulating the ubiquitination of Smad2 through direct interactions with its EF-hand 4 domain. This study reveals a previously unidentified profibrotic mechanism of crosstalk between macrophages and HSCs in the liver and suggests an attractive novel therapeutic strategy for treating fibroproliferative liver diseases.

1 May 2019 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
YTYujen Tseng
Yujen Tseng
WDWei-Qun Ding
Wei-Qun Ding
LZLiang Zhong
Liang Zhong
JCJian Chen
Jian Chen
ZLZhongguang Luo
Zhongguang Luo
Chronic active Esptein-Barr virus (CAEBV) enteritis if rarely observed in immunocompetent patients and can be often misdiagnosed as inflammatory bowel disease. We hereby present a case of CAEBV enteritis diagnosed with double-balloon enteroscopy and EBER in-situ hybridization. This case demonstrates the clinical presentation and diagnosis of CAEBV enteritis and highlights the importance of early recognition of the disease.